These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 8958521)
1. Expression of NF2 gene product merlin in arachnoid villi and meningiomas. Sakuda K; Kohda Y; Matsumoto T; Park C; Seto A; Tohma Y; Hasegawa M; Kida S; Nitta H; Yamashima T; Yamashita J Noshuyo Byori; 1996 Nov; 13(2):145-8. PubMed ID: 8958521 [TBL] [Abstract][Full Text] [Related]
2. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas. Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247 [TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants. Wellenreuther R; Waha A; Vogel Y; Lenartz D; Schramm J; Wiestler OD; von Deimling A Lab Invest; 1997 Dec; 77(6):601-6. PubMed ID: 9426397 [TBL] [Abstract][Full Text] [Related]
4. Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases. Maxwell M; Shih SD; Galanopoulos T; Hedley-Whyte ET; Cosgrove GR J Neurosurg; 1998 Mar; 88(3):562-9. PubMed ID: 9488313 [TBL] [Abstract][Full Text] [Related]
5. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas. Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of NF2 gene deletion in pediatric meningiomas using chromogenic in situ hybridization. Begnami MD; Rushing EJ; Santi M; Quezado M Int J Surg Pathol; 2007 Apr; 15(2):110-5. PubMed ID: 17478763 [TBL] [Abstract][Full Text] [Related]
7. [Neurofibromatosis type 2 (NF2)]. Araki N; Takeshima H; Saya H Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136 [TBL] [Abstract][Full Text] [Related]
8. Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell types. James MF; Stivison E; Beauchamp R; Han S; Li H; Wallace MR; Gusella JF; Stemmer-Rachamimov AO; Ramesh V Mol Cancer Res; 2012 May; 10(5):649-59. PubMed ID: 22426462 [TBL] [Abstract][Full Text] [Related]
9. Altered expression of beta-catenin/E-cadherin in meningiomas. Brunner EC; Romeike BF; Jung M; Comtesse N; Meese E Histopathology; 2006 Aug; 49(2):178-87. PubMed ID: 16879395 [TBL] [Abstract][Full Text] [Related]
10. Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth. James MF; Lelke JM; Maccollin M; Plotkin SR; Stemmer-Rachamimov AO; Ramesh V; Gusella JF Neurobiol Dis; 2008 Feb; 29(2):278-92. PubMed ID: 17962031 [TBL] [Abstract][Full Text] [Related]
11. NF2: the wizardry of merlin. Xiao GH; Chernoff J; Testa JR Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860 [TBL] [Abstract][Full Text] [Related]
12. Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas. Kimura Y; Saya H; Nakao M Neuropathology; 2000 Sep; 20(3):153-60. PubMed ID: 11132929 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer. Ikeda K; Saeki Y; Gonzalez-Agosti C; Ramesh V; Chiocca EA J Neurosurg; 1999 Jul; 91(1):85-92. PubMed ID: 10389885 [TBL] [Abstract][Full Text] [Related]
14. The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP. Striedinger K; VandenBerg SR; Baia GS; McDermott MW; Gutmann DH; Lal A Neoplasia; 2008 Nov; 10(11):1204-12. PubMed ID: 18953429 [TBL] [Abstract][Full Text] [Related]